552NewsOPPO Technologies Empower Global Fans to Immerse Themselves in the Excitement of Sports
LONDON, UK – Media OutReach – 17 July 2023 – It’s only July and sports fans around the world can already count...
- 443Wire Stories
VMware Explore 2023—the Center of the Multi-Cloud Universe—to Feature Multiple Keynotes, Technology Innovation Showcase, Hands on Labs, and Much More
PALO ALTO, Calif.–(BUSINESS WIRE)–VMware, Inc. (NYSE: VMW) today announced highlights of the VMware Explore 2023 season, which is the global multi-cloud industry...
- 430Wire Stories
Fisker Announces Fisker Extreme Vigyan Limited Edition for India Market
Fisker will produce 100 Fisker Extreme Vigyan Edition all-electric SUVs for the India market. Fisker expects to complete the homologation process for...
- 447Wire Stories
Can-Fite: Granted Breakthrough Abstract Award for Namodenoson in Treatment of Advanced Liver Cancer by ASCO Conquer Cancer Foundation
Can-Fite’s novel approach for the treatment of advanced liver cancer will be presented at the American Society of Clinical Oncology (ASCO) Breakthrough...
- 499News
Klaytnovators Hackathon: The first Vietnam-edition coding contest to unleash creativity
With a prize pool of up to 300,000,000 VND, Klaytnovators Hackathon offers an opportunity for talented young individuals passionate about technology to...
- 402News
Bybit VIPs to Embark on an Unforgettable Journey at the Lamborghini Super Trofeo Asia 2023
DUBAI, UNITED ARAB EMIRATES – Media OutReach – 17 July 2023 – Bybit, the world’s third most visited crypto exchange and sponsor...
- 520Wire Stories
Securian Canada Selects the FINEOS Platform to Expand Disability Management Offering
ATLANTA–(BUSINESS WIRE)–#digitaltransformation—FINEOS Corporation (ASX:FCL) announced today that Securian Canada has selected FINEOS for its disability management claims administration software solution. Securian Canada...
- 431Wire Stories
HighField Biopharmaceuticals Announces First Patient Dosed in Phase 1b/2 Trial of HF1K16 for Recurrent and Refractory Glioma
HF1K16 is a new immuno-oncology drug targeting myeloid-derived suppressor cells (MDSC) to treat cancer HANGZHOU, CHINA–(BUSINESS WIRE)–HighField Biopharmaceuticals (HighField Bio), a clinical...
- 502News
Gentari Appoints Navjit Gill as India’s Country Head
Navjit brings over three decades of experience in the energy and marine sectors KUALA LUMPUR, MALAYSIA – Media OutReach – 17 July...
- 506News
Origin Property Launches The Origin Kathu – Patong Condominium Project
The 617-unit development in Phuket, Thailand, is being offered to Hong Kong investors seeking a prime location, the finest facilities and a...
